肝-暴露组轴:内分泌干扰物如何劫持肝脏受体驱动MASLD
本综述提出「肝-暴露组轴」框架,将特定内分泌干扰物(EDC)类别映射至核受体(NR)及脂质代谢、糖稳态、线粒体功能和炎症信号通路,整合体内外研究证据,阐明不同EDC家族通过重叠分子签名促进肝脏促脂肪变性和促炎微环境,并讨论脆弱人群、暴露关键窗口、混合物效应和性别特异性反应,提出机制与转化研究优先方向。
要点
- EDC通过劫持AhR、PXR、CAR、PPARs、FXR、LXRs、RXR等核受体干扰肝脏代谢调控。
- 有机氯农药、拟除虫菊酯、双酚类、邻苯二甲酸酯、有机磷酸酯和PFAS等EDC与肝病相关。
- EDC暴露是MASLD轨迹的环境修饰因素,需关注混合物效应和性别特异性反应。
核心结论
- 定义明确的EDC通过重编程肝脏转录和代谢网络参与MASLD发生发展,肥胖、饮食和遗传不能完全解释全球MASLD增速。
- 「肝-暴露组轴」以受体为中心,将特定EDC类别映射至核受体及MASLD相关关键代谢通路。
- 不同EDC家族在控制de novo脂肪生成、β-氧化、糖处理、抗氧化防御和炎症/免疫信号的通路上留下重叠分子签名,共同营造促脂肪变性和促炎肝脏微环境。
研究设计与样本
- 综述整合体内和体外研究证据,聚焦主要EDC家族与肝脏代谢调控的分子界面。
主要发现
- 有机氯农药、拟除虫菊酯、双酚类、邻苯二甲酸酯、有机磷酸酯和PFAS等EDC组与肝病相关。
- AhR、PXR、CAR、PPARs、FXR、LXRs、RXR等异源物感应和代谢核受体是EDC作用的汇聚点。
- EDC暴露涉及脆弱人群、暴露关键窗口、混合物效应和性别特异性反应,作为环境修饰因素影响全生命周期MASLD轨迹。
关键数值与推荐
- 提出「肝-暴露组轴」作为受体中心框架,映射EDC类别至核受体和MASLD相关代谢通路。
临床怎么用
- 将EDC作为MASLD的环境修饰因素纳入全生命周期评估,关注脆弱人群和暴露关键窗口。
局限性
- 综述未报告具体样本量、效应量或阈值等定量数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing worldwide at a pace that cannot be fully explained by obesity, diet, or genetics alone. Emerging evidence provides mechanistic insight into how defined endocrine-disrupting chemicals (EDCs) rewire hepatic transcriptional and metabolic networks relevant to MASLD. This review focuses on the molecular interfaces through which major EDC families intersect with hepatic metabolic regulation. We propose the "hepato-exposome axis" as a receptor-centric framework that maps specific EDC classes to nuclear receptors (NRs) and key metabolic pathways involved in lipid metabolism, glucose homeostasis, mitochondrial function, and inflammatory signalling that are implicated in MASLD progression. We summarise key EDC groups linked to liver disease, including organochlorine pesticides, pyrethroids, bisphenols, phthalates, organophosphate esters, and per- and polyfluoroalkyl substances (PFAS). We then integrate current understanding of hepatic metabolic and xenobiotic pathways in homeostasis and MASLD, emphasising xenobiotic-sensing and metabolic NRs (AhR, PXR, CAR, PPARs, FXR, LXRs, RXR) as convergence points for EDC action. Drawing on in vivo and in vitro studies, we show that distinct EDC families imprint overlapping molecular signatures onto pathways that control de novo lipogenesis, β-oxidation, glucose handling, antioxidant defences, and inflammatory/immune signalling, collectively fostering a pro-steatotic and pro-inflammatory hepatic milieu. We further discuss vulnerable populations, critical windows of exposure, mixture effects, and sex-specific responses, positioning EDCs as environmental modifiers of the MASLD trajectory across the life course. Finally, we outline priorities for mechanistic and translational research, including mixture toxicology, multi-omics exposome profiling, and biomarker discovery, to better quantify and mitigate endocrine disruptors' contribution to the global MASLD burden.
引用
- Martín-Grau M, Kamstra JH, Hyötyläinen T, et al. The hepato-exposome axis: How endocrine disruptors hijack liver receptors to drive MASLD. J Hepatol. 2026. PMID: 42331229. doi:10.1016/j.jhep.2026.06.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。